Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0760
D

Failure to Discontinue Anticoagulant as Ordered After INR Reached Therapeutic Range

Hollidaysburg, Pennsylvania Survey Completed on 12-10-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A review of facility policy, clinical records, and staff interviews revealed that the facility failed to administer medication as ordered by the physician, resulting in a significant medication error for one resident. The facility's policy required medications to be administered according to prescriber orders, including any specified time frames. A resident with diagnoses of atrial fibrillation and an arterial aneurysm was discharged from the hospital with an order to receive 50 mg of enoxaparin daily until the resident's INR reached a therapeutic range. Laboratory results showed that the resident's INR was within the therapeutic range on September 17, 2025. Despite the INR being in the therapeutic range, the Medication Administration Record indicated that enoxaparin was still administered on September 18 and 19, contrary to the physician's order. The DON confirmed that the medication should have been discontinued once the INR was therapeutic, but it was not, resulting in the resident receiving unnecessary doses. This failure to discontinue the medication as ordered constituted a significant medication error.

An unhandled error has occurred. Reload 🗙